0O

Athens Medical Center SALSE Athens Medical Stock Report

Last reporting period 31 Dec, 2023

Updated —

Last price

Market cap $B

0.116

Micro

Exchange

XLON - London Stock Exchange

0ONM.L Stock Analysis

0O

Avoid

Based on Eyestock quantitative analysis, 0ONM.L`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

31/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

1.4 %

Undervalued

Market cap $B

0.116

Dividend yield

2.84 %

Shares outstanding

86.736 B

Athens Medical Center SA engages in the provision of health care services. The company is headquartered in Athina, Attiki and currently employs 3,088 full-time employees. The firm is involved in the organization, management and modernization of hospitals in Greece and abroad, the development of special activities with the aim of promoting medical research and methods of treatment, the training and selection of executives and staff on behalf of the hospitals and the importation of medical tools, instruments, machinery and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. The company operates seven clinics in Athens and suburbs, Trans-Balkan Medical Center in Thessaloniki, two medical centers in Romania, one in Cyprus and a number of diagnostic centers located throughout Greece.

View Section: Eyestock Rating